Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival

Introduction Hepatocellular carcinoma (HCC) is a common cause of cancer-related death, often detected in the intermediate stage. The standard of care for intermediate-stage HCC is transarterial chemoembolisation (TACE), where idarubicin (IDA) is a promising drug. Despite the fact that TACE has been...

Full description

Bibliographic Details
Main Authors:	Fredrik Rorsman, Ulrika S H Simonsson, Håkan Ahlström, Sofi Sennefelt Nyman, Angeliki Dimopoulou Creusen, David Dahlgren, Mikael Hedeland, Femke Heindryckx, Ulf Johnson, Jaafar Khaled, Fredrik Kullenberg, Rickard Nyman, Reza Sheikhi, Erik Sjögren, Alkwin Wanders, Hans Lennernäs, Charlotte Ebeling Barbier
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-11-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/12/11/e065839.full

Similar Items

Orthogonality in Principal Component Analysis Allows the Discovery of Lipids in the Jejunum That Are Independent of Ad Libitum Feeding
by: David Balgoma, et al.
Published: (2022-09-01)

Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
by: David Balgoma, et al.
Published: (2021-05-01)

Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
by: Maria Kopsida, et al.
Published: (2024-01-01)

In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
by: Fredrik Kullenberg, et al.
Published: (2021-07-01)

Prevention of Rat Intestinal Injury with a Drug Combination of Melatonin and Misoprostol
by: David Dahlgren, et al.
Published: (2020-09-01)

Reshaping the narrative: Tracing the historical trajectory of HIV/AIDS, gay men, and public health in Sweden
by: Fredrik Nyman
Published: (2024-01-01)

Reshaping the narrative: Tracing the historical trajectory of HIV/AIDS, gay men, and public health in Sweden.
by: Fredrik Nyman
Published: (2024-01-01)

Health care of the disadvantaged: chronic obstructive pulmonary disease in later life
by: Fredrik Nyman
Published: (2023-11-01)

Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma
by: Charlotte Ebeling Barbier, et al.
Published: (2021-12-01)

The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
by: David Dahlgren, et al.
Published: (2020-01-01)

Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats
by: Maria-José Cano-Cebrián, et al.
Published: (2022-01-01)

Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models
by: David Dahlgren, et al.
Published: (2020-09-01)

Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats
by: David Dahlgren, et al.
Published: (2021-06-01)

Treatment of Large Hepatocellular Carcinoma using Transarterial Chemoembolisation Combined with Sorafenib
by: SD Madhu, et al.
Published: (2021-01-01)

Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
by: Ilse R. Dubbelboer, et al.
Published: (2019-07-01)

The structure of an idarubicin-d(TGATCA) complex at high resolution.
by: Gallois, B, et al.
Published: (1993)

Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis
by: Johan Vessby, et al.
Published: (2019-10-01)

Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
by: Abdullah Taşkın, et al.
Published: (2019-10-01)

Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles
by: Carole Barbey, et al.
Published: (2021-01-01)

Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
by: Gauri Mishra, et al.
Published: (2020-05-01)

Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat
by: David Dahlgren, et al.
Published: (2020-03-01)

Correction to “Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles”
by: Carole Barbey, et al.
Published: (2022-06-01)

Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region
by: Ana Matilla Peña, et al.
Published: (2015-03-01)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01)

Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation
by: Kai Lei, et al.
Published: (2023-08-01)

Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective
by: David Dahlgren, et al.
Published: (2020-06-01)

Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation
by: David Dahlgren, et al.
Published: (2023-06-01)

Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches
by: David Dahlgren, et al.
Published: (2019-08-01)

Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
by: Luna Prieto Garcia, et al.
Published: (2022-09-01)

Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein
by: Ying Zhang, et al.
Published: (2022-12-01)

Carbon-based ruthenium nanomaterial-based electroanalytical sensors for the detection of anticancer drug Idarubicin
by: S. Irem Kaya, et al.
Published: (2020-07-01)

A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
by: Xiaonan Shi, et al.
Published: (2023-11-01)

Cost-effectiveness analysis of adding transarterial chemoembolisation to lenvatinib as first-line treatment for advanced hepatocellular carcinoma in China
by: Wei Li, et al.
Published: (2023-09-01)

Clinical outcome and analysis of procedural failure during uterine artery chemoembolisation as a treatment of caesarean scar pregnancy
by: Krzysztof Pyra, et al.
Published: (2020-11-01)

Transarterial chemoembolisation of colorectal liver metastases with irinotecan-loaded beads: What every interventional radiologist should know
by: Roberto Iezzi, et al.
Published: (2020-01-01)

Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
by: Jaafar Khaled, et al.
Published: (2022-02-01)

Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study
by: Huixia Qin, et al.
Published: (2023-12-01)

Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Alexander Lawson, et al.
Published: (2023-06-01)

Incidence of acute kidney injury and assessment of its associated risk factors in patients undergoing transarterial chemoembolisation for hepatocellular carcinoma
by: Kamran Muddasar Saeed, et al.
Published: (2022-01-01)

The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis
by: Zhoujing Cheng, et al.
Published: (2020-09-01)